Login / Signup

Retreatment Efficacy and Renal Safety of Tenofovir Alafenamide, Entecavir, and Tenofovir Disoproxil Fumarate After Entecavir or Tenofovir Cessation.

Shao-Ming ChiuKuo-Chin ChangTsung-Hui HuChao-Hung HungJing-Houng WangSheng-Nan LuChien-Hung Chen
Published in: Digestive diseases and sciences (2022)
TAF could be one of the retreatment options for retreatment of HBV relapse after entecavir or TDF cessation.
Keyphrases
  • antiretroviral therapy
  • hepatitis b virus
  • liver failure